Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,269 | 2 | 51.8% |
| Food and Beverage | $6,623 | 169 | 28.0% |
| Travel and Lodging | $4,732 | 9 | 20.0% |
| Education | $70.93 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neuronetics, Inc. | $18,708 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,621 | 19 | $0 (2024) |
| ITI, Inc. | $767.12 | 30 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $471.02 | 23 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $368.39 | 17 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $326.76 | 12 | $0 (2024) |
| ABBVIE INC. | $289.63 | 16 | $0 (2024) |
| Lundbeck LLC | $273.54 | 11 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $222.44 | 9 | $0 (2024) |
| Bausch Health US, LLC | $207.37 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,924 | 76 | Neuronetics, Inc. ($17,432) |
| 2023 | $1,893 | 67 | ITI, Inc. ($566.86) |
| 2022 | $1,610 | 26 | Neuronetics, Inc. ($1,019) |
| 2021 | $38.41 | 2 | Lundbeck LLC ($38.41) |
| 2018 | $175.18 | 9 | Alkermes, Inc. ($67.84) |
| 2017 | $54.59 | 3 | Otsuka America Pharmaceutical, Inc. ($54.59) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $34.16 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Education | In-kind items and services | $11.87 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Travel and Lodging | Cash or cash equivalent | $1,293.70 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 08/23/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $602.61 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 08/23/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $498.52 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 08/22/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $96.85 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 08/02/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $369.00 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 07/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: Neuropsychiatry | ||||||
| 07/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: PSYCHIATRY | ||||||
| 07/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: PSYCHIATRY | ||||||
| 07/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.62 | General |
| Category: PSYCHIATRY | ||||||
| 06/26/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $21.02 | General |
| 06/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: PSYCHIATRY | ||||||
| 06/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: CNS | ||||||
| 06/17/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 2 | 69 | 259 | $35,532 | $8,922 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 58 | 243 | $32,670 | $7,951 | 24.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 11 | 16 | $2,862 | $970.47 | 33.9% |
About Dr. Shahrzad Sims, D.O
Dr. Shahrzad Sims, D.O is a Psychiatry healthcare provider based in Brockton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2013. The National Provider Identifier (NPI) number assigned to this provider is 1689015539.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shahrzad Sims, D.O has received a total of $23,695 in payments from pharmaceutical and medical device companies, with $19,924 received in 2024. These payments were reported across 183 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,269).
As a Medicare-enrolled provider, Sims has provided services to 69 Medicare beneficiaries, totaling 259 services with total Medicare billing of $8,922. Data is available for 1 year (2020–2020), covering 2 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Brockton, MA
- Active Since 07/08/2013
- Last Updated 04/24/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1689015539
Products in Payments
- NEUROSTAR TMS THERAPY SYSTEM (Device) $18,708
- SPRAVATO (Drug) $1,561
- CAPLYTA (Drug) $1,238
- REXULTI (Drug) $375.28
- VRAYLAR (Drug) $289.63
- HETLIOZ (Drug) $250.49
- INGREZZA (Drug) $222.44
- APLENZIN (Drug) $207.37
- ABILIFY MYCITE (Drug) $126.50
- TRINTELLIX (Drug) $112.33
- ABILIFY MAINTENA (Drug) $101.74
- FANAPT (Drug) $76.27
- Aristada 441 mg (Drug) $67.84
- INVEGA SUSTENNA (Drug) $59.91
- Qelbree (Drug) $41.84
- QELBREE (Drug) $41.72
- BRINTELLIX (Drug) $38.41
- ARISTADA (Drug) $28.03
- LYBALVI (Drug) $26.55
- UZEDY (Drug) $23.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Brockton
Andrey Gagarin, M.d, M.D
Psychiatry — Payments: $13,412
Gary Kaplan, Md, MD
Psychiatry — Payments: $10,750
Dr. Lyudmila Rakita, Md, MD
Psychiatry — Payments: $8,002
Ryan Lydon, Md, MD
Psychiatry — Payments: $417.36
Bernard Waigi
Psychiatry — Payments: $403.98
Dr. Mathews Thomas, M.d, M.D
Psychiatry — Payments: $362.90